GeneDx Reports First Quarter 2024 Financial Results and Business Highlights

Go back to GeneDx Reports First Quarter 2024 Financial Results and Business Highlights

GeneDx (WGS) PT Raised to $19 at BTIG

April 30, 2024 4:52 AM EDT

BTIG analyst Mark Massaro raised the price target on GeneDx (NASDAQ: WGS) to $19.00 (from $15.00) while maintaining a Buy rating.

The analyst comments "Shares of WGS are up 30% in the after hours (and are up 300% YTD prior to the Q1 earnings call) after the... More